IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MONTI, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.469
AS - Asia 2.249
EU - Europa 1.493
SA - Sud America 262
AF - Africa 46
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.556
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.355
SG - Singapore 663
CN - Cina 637
IT - Italia 398
VN - Vietnam 245
HK - Hong Kong 195
GB - Regno Unito 185
BR - Brasile 181
RU - Federazione Russa 167
FR - Francia 161
JP - Giappone 127
DE - Germania 123
BD - Bangladesh 111
IN - India 95
CA - Canada 75
IE - Irlanda 71
ES - Italia 64
NL - Olanda 57
SE - Svezia 50
FI - Finlandia 43
ID - Indonesia 39
CL - Cile 29
AU - Australia 27
TR - Turchia 26
BE - Belgio 23
KR - Corea 23
MX - Messico 23
PL - Polonia 22
DK - Danimarca 21
CH - Svizzera 17
AR - Argentina 14
EC - Ecuador 13
PT - Portogallo 13
TH - Thailandia 13
GR - Grecia 12
AT - Austria 11
EG - Egitto 11
PE - Perù 11
PK - Pakistan 11
IL - Israele 10
TW - Taiwan 10
ZA - Sudafrica 9
MA - Marocco 8
NZ - Nuova Zelanda 8
CO - Colombia 7
SA - Arabia Saudita 7
SI - Slovenia 7
TN - Tunisia 7
BG - Bulgaria 6
RO - Romania 6
UA - Ucraina 6
CZ - Repubblica Ceca 5
IQ - Iraq 5
NO - Norvegia 5
HU - Ungheria 4
IR - Iran 4
JM - Giamaica 4
RS - Serbia 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
CI - Costa d'Avorio 3
JO - Giordania 3
PH - Filippine 3
PY - Paraguay 3
AZ - Azerbaigian 2
BH - Bahrain 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
EU - Europa 2
KE - Kenya 2
LT - Lituania 2
LU - Lussemburgo 2
LV - Lettonia 2
MN - Mongolia 2
MT - Malta 2
PA - Panama 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
MF - Saint Martin 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 6.553
Salva come PNG Salva come JPEG
Città #
Dallas 488
Ashburn 257
Singapore 256
San Jose 180
Hong Kong 134
Milan 90
Fairfield 89
Council Bluffs 81
Ho Chi Minh City 75
Chandler 71
Los Angeles 65
Redwood City 63
Hefei 60
Dublin 59
Beijing 56
Hanoi 56
Lauterbourg 53
Houston 52
Princeton 48
Rome 48
Guangzhou 47
Wilmington 47
Woodbridge 47
Buffalo 45
Southend 45
New York 42
Moscow 41
Tokyo 41
Santa Clara 39
Seattle 37
Cambridge 36
Delhi 36
Frankfurt am Main 34
São Paulo 33
London 28
Helsinki 27
Madrid 26
Bengaluru 25
Chicago 25
Ann Arbor 24
Boardman 23
Jakarta 23
Santiago 23
Da Nang 21
Des Moines 21
Munich 19
Seoul 17
Paris 16
Shenzhen 16
Montreal 15
Phoenix 15
Shanghai 14
Shenyang 14
Ottawa 13
Central District 12
Manchester 12
Warsaw 12
Hanover 11
Naples 11
Tianjin 11
Toronto 11
Bangkok 10
Boston 10
Columbus 10
Dearborn 10
Florence 10
Brussels 9
Cangzhou 9
Dong Ket 9
Haiphong 9
Istanbul 9
Jinan 9
Nanjing 9
Osaka 9
San Diego 9
The Dalles 9
Amsterdam 8
Atlanta 8
Changsha 8
Hangzhou 8
Mexico City 8
Milwaukee 8
Athens 7
Hebei 7
Lappeenranta 7
Lille 7
Lima 7
Porto 7
Salt Lake City 7
Taiyuan 7
Turku 7
Washington 7
Zhengzhou 7
Cairo 6
Costa Mesa 6
Denver 6
Lahore 6
Palermo 6
Redondo Beach 6
Renswoude 6
Totale 3.643
Salva come PNG Salva come JPEG
Nome #
Randomized controlled trials and real-world data : differences and similarities to untangle literature data 774
20 years of experience with tumour necrosis factor inhibitors : what have we learned? 518
Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factors 396
Retrospective evaluation of patient profiling and effectiveness of apremilast in an Italian multicentric cohort of psoriatic arthritis patients 225
Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors 215
Chronic pain : the burden of disease and treatment innovations 185
Alveolar haemorrhage in ANCA-associated vasculitis : Long-term outcome and mortality predictors 174
Incidence of COVID-19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data? 155
Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes 154
Pneumocephalus due to granulomatosis with polyangiitis 151
The multifaceted aspects of interstitial lung disease in rheumatoid arthritis 151
Identification of two autoantigens recognised by circulating autoantibodies as potential biomarkers for diagnosing giant cell arteritis 151
Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment : extending perspective from old to newer drugs 136
The impact of disease extent and severity detected by quantitative ultrasound analysis in the diagnosis and outcome of giant cell arteritis 127
Disease and treatment-related morbidity in young and elderly patients with granulomatosis with polyangiitis and microscopic polyangiitis 125
Psychosocial burden in young patients with primary anti-phospholipid syndrome: an Italian nationwide survey (The AQUEOUS study) 121
Perivascular fibrosis and IgG4-related disease : a case report 119
Rheumatoid arthritis treatment : the earlier the better to prevent joint damage 119
Prognostic factors and long-term outcome with anca-associated kidney vasculitis in childhood 114
Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis : real-life data from the Italian LORHEN Registry 109
Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for Rheumatology 108
The use of ultrasound in the management of large-vessel vasculitis: an evolving concept 98
One year in review 2017: spondyloarthritis 93
Influence of gender on Behçet's disease phenotype and irreversible organ damage: Data from the International AIDA Network Behçet's Disease Registry 91
The role of extra-corporeal membrane oxygenation (ECMO) in the treatment of diffuse alveolar haemorrhage secondary to ANCA-associated vasculitis : report of two cases and review of the literature 90
Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory Disorders 89
Humoral and T-cell immune response following three doses of SARS-CoV-2 mRNA vaccine in giant cell arteritis: analysis of a prospective cohort 89
A patient-driven registry on Behçet’s disease: the AIDA for patients pilot project 87
Aging in Primary Systemic Vasculitis: Implications for Diagnosis, Clinical Manifestations, and Management 87
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 83
Early development of new cardiovascular risk factors in the systemic vasculitides 80
Ultrasound halo sign as a potential monitoring tool for patients with giant cell arteritis: a prospective analysis 78
Factors influencing patient-reported outcomes in ANCA-associated vasculitis: correlates of the Patient Global Assessment 77
Fast-Track Ultrasound Clinic for the Diagnosis of Giant Cell Arteritis Changes the Prognosis of the Disease but Not the Risk of Future Relapse 76
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies 76
Development and implementation of the AIDA International Registry for patients with Behçet’s disease 74
Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis 73
Remission and Low-Disease Activity in Granulomatosis with Polyangiitis and Microscopic Polyangiitis: Prevalence and Impact on Damage Accrual 73
The role of Trimethoprim/sulfametoxazole in reducing relapses and risk of infec-tions in ANCA-associated vasculitis: a meta-analysis 72
Life-threatening onset of systemic vasculitis requiring intensive care unit admission: a case series 68
Azathioprine vs methotrexate in eosinophilic granulomatosis with polyangiitis: a monocentric retrospective study 63
The proposed role of ultrasound in the management of giant cell arteritis in routine clinical practice 62
How I treat idiopathic patients with inflammatory myopathies in the clinical practice 59
Updates on the diagnosis and monitoring of giant cell arteritis 59
Switching from intravenous to subcutaneous formulation of abatacept : different results in a series of 21 patients 56
Spinal non-Hodgkin’s lymphoma mimicking a flare of disease in a patient with ankylosing spondylitis treated with anti-TNF agents : case report and review of the literature 53
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 53
Striking abdominal aortic stenosis revealing Takayasu's arteritis 46
Cytomegalovirus colitis unmasking human immunodeficiency virus infection as a cause of IgA vasculitis 42
One year in review 2018: psoriatic arthritis 40
Novel therapies for ANCA-associated vasculitis 40
2018 Update of the EULAR Recommendations for the Management of Large Vessel Vasculitis 39
ANCA-associated vasculitis in childhood: recent advances 39
Correspondence on EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs 38
Management of Takayasu arteritis: a systematic literature review informing the 2018 update of the EULAR recommendations for the management of large vessel vasculitis 38
One year in review 2019: vasculitis 36
One year in review 2020: vasculitis 35
Circulating suPAR levels are affected by glomerular filtration rate and proteinuria in primary and secondary glomerulonephritis 32
One year in review 2018: systemic vasculitis 30
The use of ultrasound to assess giant cell arteritis: review of the current evidence and practical guide for the rheumatologist 30
One year in review 2017: systemic vasculitis 29
A new era for the early and non-invasive diagnosis of giant cell arteritis: the use of fast-track ultrasound in clinical practice 27
Immunosuppressive treatments selectively affect the humoral and cellular response to SARS-CoV-2 in vaccinated patients with vasculitis 20
null 3
The giant cell arteritis (GCA) ultrasound score (OGUS) at diagnosis and after initial treatment predicts future relapses in GCA patients: results of a multicentre prospective study 3
Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: Data from a European multicentre study 2
Totale 6.855
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.931
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.931
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202142 0 0 0 0 0 0 0 0 0 0 0 42
2021/2022368 18 15 32 35 23 19 17 29 22 59 31 68
2022/2023444 59 25 20 35 32 81 18 31 43 18 40 42
2023/2024360 13 34 18 24 76 15 29 34 16 26 37 38
2024/2025914 31 53 17 79 59 54 44 92 70 73 130 212
2025/20263.849 220 185 856 310 352 203 419 209 395 213 287 200
Totale 6.855